Mirae Asset Venture Investment
VC Fund
Seongnam, South Korea
Mirae Asset Venture Investment is a VC fund in Seongnam focused on Software and Artificial Intelligence. Mirae Asset Venture Investment invests in specialized enterprises and provides technology, funding and management consulting.
- Total investments:
- 338
- Last investment:
- Lead investor:
- 14%
- Fund size:
- $118M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Mirae Asset Venture Investment invests in
Stages Mirae Asset Venture Investment invests in
Countries Mirae Asset Venture Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 10 contacts → | |||
Round size
- Seed
- $594k–$14M
- Series A
- $2M–$40M
- Series B
- $5M–$52M
Investment Focus
Industry
- Software 41 (12%)
- Artificial Intelligence 37 (11%)
- Biotechnology 35 (10%)
- Information Technology 32 (9%)
- Health Care 26 (8%)
Stage
- Series A 97 (29%)
- Series B 78 (23%)
- Seed 47 (14%)
- Series C 33 (10%)
- Funding Round 15 (4%)
Country
- South Korea 163 (48%)
- United States 40 (12%)
- India 11 (3%)
- China 8 (2%)
- Singapore 4 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chirag Heda
Chief Executive Officer
|
Chief Executive Officer | Total investments: 17 | Find email | |
Chirag Heda
Chief Executive Officer
|
Chief Executive Officer | Total investments: 14 | Find email | |
Eunhye Haley Kim
Senior investment manager
|
Senior investment manager | Total investments: 0 | Find email | |
Jinhwan Cho
General Manager
|
General Manager | Total investments: 5 | Find email | |
Ashish Dave
CEO
|
CEO | Total investments: 7 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Nexedge is a wealth management firm that offers investment management, estate planning, and business advisory services. | $20M / Series A / Aug 25, 2026 | ||
| iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing. | $37.1M / Series A / Aug 19, 2026 | ||
| HEM Pharma is a biotechnology firm that focuses on personalized microbiome healthcare, live biotherapeutic drug (LBP) development, microbiome analysis, and health-functional food manufacturing. The company leverages proprietary microbiome technologies to develop individualized health solutions and next-generation microbiome-based therapeutics. andsupporting personalized microbiome solutions and functional nutrition products. HEM Pharma has expanded internationally through its Japanese subsidiary and global research partnerships. | $38.3M / Post-IPO Debt / Aug 18, 2026 | ||
| StepLab is a microsatellite systems company specializing in space mechanism technology, developing innovative satellite platforms and advanced aerospace solutions that support efficient satellite deployment, in-orbit operations, and a wide range of commercial and scientific space missions. | $7.7M / Series A / Aug 05, 2026 | ||
| Flexell Space engages in space solar cells, focusing on improving cost, delivery, design, and power efficiency. | $20M / Series A / Jul 14, 2026 | ||
Linq
|
We are creating ‘hyper-automated insurance platforms’ to comprehensively support underwriters and claim adjusters and to facilitate communication between insurers and reinsurers using AI and deep learning. | $22M / Series A / Jul 02, 2026 | |
| XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing. | $135M / Series B / May 29, 2026 | ||
| Asteromorph is an artificial intelligence (AI) research startup for the development of scientific superintelligence | $31.3M / Seed / May 29, 2026 | ||
| Tynapse develops artificial intelligence security and governance software focused on monitoring and controlling AI agents in enterprise environments. The company provides a runtime trust layer that evaluates AI-generated outputs, tool usage, and automated actions in real time to identify risks such as hallucinations, prompt injection attacks, dataleakage, and unauthorized behavior. Its platform includes AI guardrails, compliance monitoring, audit logging, and explainability tools designed to support regulatory and operational oversight for AI systems. Tynapse also generates traceability records and trust attestation documentation that organizations can use for governance and compliance processes. The company’s technology integrates between enterprise applications and large language models to inspect requests, enforce policies, and manage sensitive data handling. Its solutions are used in sectors such as finance and enterprise software where AI systems require security controls, monitoring, and accountability mechanisms. | $3.2M / Seed / Apr 28, 2026 | ||
| Upstage AI develops artificial intelligence technologies focused on large language models and document processing systems designed to support enterprise workflows. Its platform includes tools that convert unstructured data such as PDFs, scans, and emails into structured, machine-readable formats, enabling downstream analysis and automation. Thecompany also provides models like its Solar LLM, which are optimized for tasks such as text generation, information extraction, and question answering within business environments. Its solutions are applied across industries including finance, healthcare, insurance, and manufacturing to handle tasks like document parsing, data extraction, and workflow automation. Additionally, its services can be deployed through APIs, cloud environments, or on-premise systems to integrate with existing enterprise infrastructure. | $121.7M / Series C / Apr 15, 2026 | ||
| See all 338 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Mirae Asset Venture Investment invest in?
Mirae Asset Venture Investment invests primarily in Software, Artificial Intelligence and Biotechnology startups, most often at Series A and Series B stage. Most of the 338 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Mirae Asset Venture Investment's check size?
Mirae Asset Venture Investment typically joins rounds of $594k–$14M at Seed, $2M–$40M at Series A and $5M–$52M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mirae Asset Venture Investment participates in.
How do I contact Mirae Asset Venture Investment?
Public channels for Mirae Asset Venture Investment include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mirae Asset Venture Investment?
The team at Mirae Asset Venture Investment includes Chirag Heda (Chief Executive Officer), Chirag Heda (Chief Executive Officer) and Eunhye Haley Kim (Senior investment manager), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
